QT
CODX

Quantbot Technologies’s Co-Diagnostics CODX Stock Holding History

Quantbot Technologies’s Portfolio CODX Stock Details CODX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-252
Closed -$46K – 1756
2022
Q1 		$46K Buy
+252
New +$52.2K ﹤0.01% 1207
2020
Q3 		– Sell
-148
Closed -$86K – 1332
2020
Q2 		$86K Buy
+148
New +$67.6K 0.01% 609

Other funds holding CODX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
GC
Globeflex Capital San Diego, California $661M AUM 50.59% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Quantbot Technologies's CODX Position: Q2 2022 in Review

Quantbot Technologies sold out of Co-Diagnostics (CODX) in Q2 2022, closing a stake of 252 shares — an estimated $46K sold.

Quantbot Technologies first reported a position in CODX in Q2 2020 and held it in 2 quarters. The position peaked at $86K in Q2 2020. 69 funds tracked by Wall St. Rank hold CODX as of Q2 2022.

  • Quantbot Technologies reported no remaining Co-Diagnostics position as of Q2 2022 after selling out during the quarter.
  • Quantbot Technologies sold 252 Co-Diagnostics shares in Q2 2022, an estimated $46K.
  • Quantbot Technologies first reported a position in Co-Diagnostics in Q2 2020 and held it in 2 quarters.
  • Quantbot Technologies's Co-Diagnostics position peaked at $86K in Q2 2020.
  • 69 funds tracked by Wall St. Rank held Co-Diagnostics as of Q2 2022.

Based on Quantbot Technologies's 13F filing for Q2 2022, filed 9 Aug 2022.